Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIOLOS postoperative oxygen trial
2024-514285-39-00Phase 3Authorised
- Sponsor
- Medical University of Graz
- Start
- Mar 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxygen gas (2 arms), sponsored by Medical University of Graz. Primary endpoint: SpO2-TWA<90 in the first two days after surgery. Planned start Mar 2025; status: authorised.
02
Drugs
oxygen gas
Beyond the preview
Go deeper on 2024-514285-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514285-39-00.